First National Bank of Hutchinson’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-7,994
Closed -$534K 123
2021
Q2
$534K Sell
7,994
-1,511
-16% -$98.5K 0.28% 61
2021
Q1
$600K Buy
9,505
+2,588
+37% +$161K 0.3% 49
2020
Q4
$425K Buy
6,917
+1,513
+28% +$93K 0.14% 65
2020
Q3
$326K Buy
5,404
+46
+0.9% +$2.77K 0.14% 73
2020
Q2
$315K Buy
5,358
+32
+0.6% +$1.91K 0.16% 66
2020
Q1
$297K Buy
5,326
+603
+13% +$36.9K 0.15% 70
2019
Q4
$303K Buy
+4,723
New +$270K 0.12% 85

Other funds holding BMY

First National Bank of Hutchinson's BMY Position: Q3 2021 in Review

First National Bank of Hutchinson sold out of Bristol-Myers Squibb (BMY) in Q3 2021, closing a stake of 7,994 shares — an estimated $534K sold.

First National Bank of Hutchinson first reported a position in BMY in Q4 2019 and held it in 7 quarters. The position peaked at $600K in Q1 2021. 2,293 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

  • First National Bank of Hutchinson reported no remaining Bristol-Myers Squibb position as of Q3 2021 after selling out during the quarter.
  • First National Bank of Hutchinson sold 7,994 Bristol-Myers Squibb shares in Q3 2021, an estimated $534K.
  • First National Bank of Hutchinson first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 7 quarters.
  • First National Bank of Hutchinson's Bristol-Myers Squibb position peaked at $600K in Q1 2021.
  • 2,293 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on First National Bank of Hutchinson's 13F filing for Q3 2021, filed 20 Oct 2021.